Laureates Meet at Lindau

In 1951, a wealthy Swedish count named Leonard Bernadotte organized a meeting of Nobel laureates in the scenic town of Lindau, Germany. His goal was to attract foreign scientists to a country whose own scientists had become isolated as a result of World War II. In the 50 years since, the purpose of the annual meetings, which alternate their focus among the Nobel categories of chemistry, physics, and physiology or medicine, has changed significantly. No longer just a mechanism for attracting fore

Written byEugene Russo
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

In 1951, a wealthy Swedish count named Leonard Bernadotte organized a meeting of Nobel laureates in the scenic town of Lindau, Germany. His goal was to attract foreign scientists to a country whose own scientists had become isolated as a result of World War II. In the 50 years since, the purpose of the annual meetings, which alternate their focus among the Nobel categories of chemistry, physics, and physiology or medicine, has changed significantly. No longer just a mechanism for attracting foreign scientists to Germany, it's become an opportunity for laureates to meet not only with one another, but with science graduate students from all over the world. The conference, now run by Leonard's wife, Sonja Bernadotte, aims to both celebrate science and enlighten young scientists.

On June 26, in honor of the meeting's 50th anniversary (moved up one year to avoid conflict with the 100th anniversary of the Nobel ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies